Qual é o preço para Dong Sung Bio Pharm.Co.,Ltd. (002210)

O preço para Dong Sung Bio Pharm.Co.,Ltd. (002210) é $1.11

Qual é a capitalização de mercado para Dong Sung Bio Pharm.Co.,Ltd. (002210)

A capitalização de mercado para Dong Sung Bio Pharm.Co.,Ltd. (002210) é $27.12M

Dong Sung Bio Pharm.Co.,Ltd. (002210) Ações em Circulação

Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.

Ano	Ações em circulação	Alterar
2026 (TTM)	25.19M	10.15%
2024	22.87M	0.00%
2023	22.87M	-0.60%
2022	23.00M	-1.58%
2021	23.37M	-0.41%
2020	23.47M	1.76%
2019	23.06M	17.64%
2018	19.61M	-1.11%
2017	19.83M	-0.54%
2016	19.93M	0.80%
2015	19.78M	6.40%
2014	18.59M	2.83%
2013	18.07M	2.49%
2012	17.64M	-0.13%
2011	17.66M	-1.89%
2010	18.00M	-1.84%
2009	18.34M	0.79%
2008	18.19M	4.52%
2007	17.40M	0.00%

Ano

Ações em circulação

Alterar

2026 (TTM)

25.19M

10.15%

2024

22.87M

0.00%

2023

22.87M

-0.60%

2022

23.00M

-1.58%

2021

23.37M

-0.41%

2020

23.47M

1.76%

2019

23.06M

17.64%

2018

19.61M

-1.11%

2017

19.83M

-0.54%

2016

19.93M

0.80%

2015

19.78M

6.40%

2014

18.59M

2.83%

2013

18.07M

2.49%

2012

17.64M

-0.13%

2011

17.66M

-1.89%

2010

18.00M

-1.84%

2009

18.34M

0.79%

2008

18.19M

4.52%

2007

17.40M

0.00%

Empresa	Ações em circulação	Diferença	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	2.40B	9,426.41%	IN

Empresa

Ações em circulação

Diferença

País